Citrulline-specific Th1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy

Arthritis and Rheumatology

Volumn 66, Issue 7, 2014, Pages 1712-1722

  James, Eddie A ^a   Rieck, Mary ^a   Pieper, Jennifer ^b   Gebe, John A ^a   Yue, Betty B ^a   Tatum, Megan ^a   Peda, Melissa ^a   Sandin, Charlotta ^b   Klareskog, Lars ^b   Malmström, Vivianne ^b   Buckner, Jane H ^a  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; CITRULLINE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; EPITOPE; HLA ANTIGEN CLASS 2; HLA DR4 ANTIGEN; HLA DRB1 ANTIGEN; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; PEPTIDE; RITUXIMAB; TETRAMER;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; EX VIVO STUDY; GENE FREQUENCY; HAPLOTYPE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; JOINT; LYMPHOCYTE ACTIVATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM; TH1 CELL; TRANSGENIC MOUSE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ARTHRITIS, RHEUMATOID; BIOLOGICAL FACTORS; CITRULLINE; EPITOPES, T-LYMPHOCYTE; HAPLOTYPES; HLA-DRB1 CHAINS; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIDDLE AGED; SYNOVIAL MEMBRANE; TH1 CELLS; VIMENTIN;

EID: 84903479375     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38637     Document Type: Article

References (41)

1. Klareskog L, Catrina AI, Paget S,. Rheumatoid arthritis. Lancet 2009; 373: 659-72.
2. McInnes IB, Schett G,. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011; 365: 2205-19.
3. Aho K, Heliovaara M, Maatela J, Tuomi T, Palosuo T,. Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol 1991; 18: 1282-4.
4. Aho K, von Essen R, Kurki P, Palosuo T, Heliovaara M,. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process. J Rheumatol 1993; 20: 1278-81.
5. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ,. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998; 101: 273-81.
6. Harre U, Georgess D, Bang H, Bozec A, Axmann R, Ossipova E, et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 2012; 122: 1791-802.
7. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurments in blood donors. Arthritis Rheum 2004; 50: 380-6.
8. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48: 2741-9.
9. Raychaudhuri S, Sandor C, Stahl EA, Freudenberg J, Lee HS, Jia X, et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 2012; 44: 291-6.
10. Cordova KN, Willis VC, Haskins K, Holers VM,. A citrullinated fibrinogen-specific T cell line enhances autoimmune arthritis in a mouse model of rheumatoid arthritis. J Immunol 2013; 190: 1457-65.
11. Hill JA, Bell DA, Brintnell W, Yue D, Wehrli B, Jevnikar AM, et al. Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J Exp Med 2008; 205: 967-79.
12. Law SC, Street S, Yu CH, Capini C, Ramnoruth S, Nel HJ, et al. T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles. Arthritis Res Ther 2012; 14: R118.
13. Von Delwig A, Locke J, Robinson JH, Ng WF,. Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis. Arthritis Rheum 2010; 62: 143-9.
14. Snir O, Rieck M, Gebe JA, Yue BB, Rawlings CA, Nepom G, et al. Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1 0401-positive humanized mice and rheumatoid arthritis patients. Arthritis Rheum 2011; 63: 2873-83.
15. Lucas M, Day CL, Wyer JR, Cunliffe SL, Loughry A, McMichael AJ, et al. Ex vivo phenotype and frequency of influenza virus-specific CD4 memory T cells. J Virol 2004; 78: 7284-7.
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
17. James EA, Moustakas AK, Bui J, Papadopoulos GK, Bondinas G, Buckner JH, et al. HLA-DR1001 presents "altered-self" peptides derived from joint-associated proteins by accepting citulline in three of its binding pockets. Arthritis Rheum 2010; 62: 2909-18.
18. Ettinger RA, Papadopoulos GK, Moustakas AK, Nepom GT, Kwok WW,. Allelic variation in key peptide-binding pockets discriminates between closely related diabetes-protective and diabetes-susceptible HLA-DQB1 06 alleles. J Immunol 2006; 176: 1988-98.
19. + T cells proliferating in response to influenza A antigen. J Clin Invest 1999; 104: R63-7.
20. + T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 2007; 27: 203-13.
21. + T cell outcomes during specific immunotherapy. J Allergy Clin Immunol 2012; 129: 544-51.
22. Gebe JA, Novak EJ, Kwok WW, Farr AG, Nepom GT, Buckner JH,. T cell selection and differential activation on structurally related HLA-DR4 ligands. J Immunol 2001; 167: 3250-6.
23. Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E,. The conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1 0401 MHC class II molecule. J Immunol 2003; 171: 538-41.
24. + T cells correlates with immunodominance in the human memory repertoire. J Immunol 2012; 188: 2537-44.
25. null T cells in rheumatoid arthritis. Arthritis Res Ther 2007; 9: R87.
26. Danke NA, Yang J, Greenbaum C, Kwok WW,. Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects. J Autoimmun 2005; 25: 303-11.
27. Monti P, Scirpoli M, Rigamonti A, Mayr A, Jaeger A, Bonfanti R, et al. Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes. J Immunol 2007; 179: 5785-92.
28. Hill JA, Wang D, Jevnikar AM, Cairns E, Bell DA,. The relationship between predicted peptide-MHC class II affinity and T-cell activation in a HLA-DRb1 0401 transgenic mouse model. Arthritis Res Ther 2003; 5: R40-8.
29. + T cells recognize diverse epitopes within GAD65: implications for repertoire development and diabetes monitoring. Immunology 2013; 138: 269-79.
30. Murphy C, Langrish C, Chen Y, Blumenschein W, McClanahan T, Kastelein R, et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-21 in joint autoimmune inflammation. J Exp Med 2003; 198: 1951-7.
31. 3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum 2010; 62: 132-42.
32. Raza K, Falciani F, Curnow SJ, Ross EJ, Lee CY, Akbar AN, et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 2005; 7: R784-95.
33. Chen L, Wang C, Leng N, Zhu P,. Combined treatment of etanercept and MTX reverses TH1/Th2, Th17/Treg imbalances in patients with rheumatoid arthritis. J Clin Immunol 2011; 31: 596-605.
34. Yao Z, Kanno Y, Kerenyi M, Stephens G, Durant L, Watford WT, et al. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 2007; 109: 4368-75.
35. Li Y, Jiang L, Zhang S, Yin L, Ma L, He D, et al. Methotrexate attenuates the Th17/IL-17 levels in peripheral blood mononuclear cells from healthy individuals and RA patients. Rheumatol Int 2013; 32: 2415-22.
36. + T cells with epigenetic immune lineage analysis. J Immunol 2011; 186: 92-102.
37. Yamada H, Nakashima Y, Okazaki K, Mawatari T, Fukushi J, Kaibara N, et al. Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann Rheum Dis 2008; 67: 1299-304.
38. Hertl M, Amagai M, Sundaram H, Stanley J, Ishii K, Katz SI,. Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals. J Invest Dermatol 1998; 110: 62-6.
39. Danke NA, Koelle DM, Yee C, Beheray S, Kwok WW,. Autoreactive T cells in healthy individuals. J Immunol 2004; 172: 5967-72.
40. Ronnelid J, Wick MC, Lampa J, Lindblad S, Nordmark B, Klareskog L, et al. Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis 2005; 64: 1744-9.
41. Modi S, Soejima M, Levesque MC,. The effect of targeted rheumatoid arthritis therapies on anti-citrullinated protein autoantibody levels and B cell responses. Clin Exp Immunol 2013; 173: 8-17.